Wikidata
public full text
CC0 1.0
Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines#802348
- Irradiation Modulates the Pharmacokinetics of Anticancer Drugs for Head and Neck Cancer#873977
- To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656#394680
- Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study#891083
- BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients#863715
Record · ID 24642
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive